RTX vs TRSG
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
RTX exhibits stable financial health with a Piotroski F-Score of 5/9, yet it is trading at a severe premium compared to its Graham Number ($73.73) and Intrinsic Value ($96.67). While the company boasts an exceptional track record of earnings beats over 25 quarters and solid revenue growth, the valuation is stretched with a PEG ratio of 2.75. This fundamental overvaluation is compounded by bearish insider sentiment and a weak technical trend, suggesting that while the business is strong, the stock price is currently decoupled from its deterministic value.
TRSG presents a dichotomy between a stable balance sheet and a failing market trajectory. The Piotroski F-Score of 5/9 indicates stable financial health, supported by a very low Debt/Equity ratio (0.17) and strong liquidity (Current Ratio 2.26). However, the stock is trading significantly above its growth-based intrinsic value ($0.35) and slightly above its Graham Number ($1.14), while suffering from a catastrophic 5-year price decline of 79.5%. While revenue growth is strong at 37%, it lags behind the sector average, and the technical trend remains entirely bearish.
Compare Another Pair
Related Comparisons
RTX vs TRSG: Head-to-Head Comparison
This page compares RTX Corporation (RTX) and Tungray Technologies Inc. (TRSG) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.